Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weifuchun Capsules for Gastric Precancerous Lesions (ChiCTR2200061082)
ChiCTR2200061082Phase 4Recruiting
- Sponsor
- Ethnic Committee of Hospital of Integrated Traditional Chinese and Western Medicine of Linping Disctrict, Hangzhou
- Start
- Oct 2021
- Countries
- 1
01
Overview
Phase 4 trial of Weifuchun Capsules in atrophic gastritis (AG), gastric preneoplasia, Intestinal metaplasia and 1 more (2 arms), sponsored by Ethnic Committee of Hospital of Integrated Traditional Chinese and Western Medicine of Linping Disctrict, Hangzhou. Primary endpoint: Gastric pathology. Started Oct 2021; status: recruiting.
02
Drugs
Weifuchun Capsules
03
Conditions
atrophic gastritis (AG)gastric preneoplasiaIntestinal metaplasiagastric dysplasia
Beyond the preview
Go deeper on ChiCTR2200061082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061082.